Crossmark

Hemopexin alleviates cognitive dysfunction after focal cerebral ischemia-reperfusion injury in rats

Crossref DOI link: https://doi.org/10.1186/s12871-019-0681-2

Published Online: 2019-01-15

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dong, Beibei https://orcid.org/0000-0002-9711-2353
Yang, Yongyan

Zhang, Zhishen

Xie, Keliang

Su, Lin

Yu, Yonghao
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81501013)

National Natural Science Foundation of China (81372033)

National Natural Science Foundation of China (81471842)

National Natural Science Foundation of China (81500961)

National Natural Science Foundation of China (81671888)

the Postgraduate Innovation Fund of '13th Five-Year comprehensive investment', Tianjin Medical University (YJSCX201820)
License Information

Text and Data Mining valid from 2019-01-15
More Information

Article History

Received: 1 October 2018

Accepted: 4 January 2019

First Online: 15 January 2019

Ethics approval

: The experimental procedures in this study were approved by the Ethics Committee for Animal Experimentation of the Medical University of Tianjin, China (Aecl2015–0158 [JIN]).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.